Deep Track Capital, LP Spring Works Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 3,479,853 shares of SWTX stock, worth $131 Million. This represents 5.66% of its overall portfolio holdings.
Number of Shares
3,479,853
Previous 4,063,676
14.37%
Holding current value
$131 Million
Previous $148 Million
15.48%
% of portfolio
5.66%
Previous 5.63%
Shares
6 transactions
Others Institutions Holding SWTX
# of Institutions
234Shares Held
67.7MCall Options Held
546KPut Options Held
29.4K-
Vanguard Group Inc Valley Forge, PA6.53MShares$246 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.44MShares$205 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.11MShares$155 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$129 Million8.76% of portfolio
-
Marshall Wace, LLP London, X02.97MShares$112 Million0.23% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.35B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...